Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits

Acta Ophthalmologica

Volumn 88, Issue 3, 2010, Pages 337-341

  Loftsson, Thorsteinn ^a   Thorisdóttir, Sigridur ^b   Fridriksdóttir, Hafrun ^a   Stefánsson, Einar ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cyclodextrin; Drug delivery; Enalapril; Enalaprilat; Glaucoma; Intraocular pressure

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN; ENALAPRIL MALEATE; ENALAPRILAT; EYE DROPS; HYDROXYPROLYL BETA CYCLODEXTRIN; PLASMA PROTEIN; TIMOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; INTRAOCULAR PRESSURE ABNORMALITY; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; ROOM TEMPERATURE; SHELF LIFE; VISCOSITY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; ENALAPRIL; ENALAPRILAT; FEMALE; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; RABBITS; TIME FACTORS; TIMOLOL; TONOMETRY, OCULAR;

EID: 77951731706     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01495.x     Document Type: Article

References (23)

1. Bhardwaj SP Singh S (2008 Study of forced degradation behaviour of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method. J Pharm Biomed Anal 46 : 113 120.
2. Brewster ME Loftsson T (2007 Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59 : 645 666.
3. Frañová S, Nosál'ová G, Antošová M Nosál' S (2005 Enalapril and diltiazem co-administration and respiratory side-effects of enalapril. Physiol Res 54 : 515 520.
4. Harrold M (2007 Angiotensin-converting enzyme inhibitors, antagonists and calcium blockers. In : Lemke TL, Williams DA, Roche VF Zito WS (eds). Foye's Principles of Medicinal Chemistry, Vol. X.
5. Ip DP Brenner GS (1987 Enalapril maleate. In : Florey K (ed Analytical Profiles of Drug Substances, Vol. 16.
6. Kaplan NM (2007 Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 370 : 804 805.
7. Loftsson T Duchêne D (2007 Cyclodextrins and their pharmaceutical applications. Int J Pharm 329 : 1 11.
8. Loftsson T Järvinen T (1999 Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36 : 59 79.
9. Loftsson T Stefánsson E (2002 Cyclodextrins in eyedrop formulations: enhanced topical delivery of corticosteroids to the eye. Acta Ophthalmol Scand 80 : 144 150.
10. Loftsson T Stefánsson E (2007 Cyclodextrins in ocular drug delivery. J Drug Del Sci Technol 17 : 3 9.
11. Loftsson T, Vogensen SB, Brewster ME Konrádsdóttir F (2007 Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 96 : 2532 2546.
12. Loftsson T, Sigurdsson HH, Konrádsdóttir F, Gísladóttir S, Jansook P Stefánsson E (2008 Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie 63 : 171 179.
13. Lotti VJ Pawlowski N (1990 Prostaglandins mediate the ocular hypotensive action of angiotensin-converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys. J Ocul Pharmacol 6 : 1 7.
14. Manschot SM, Gispen WH, Kappelle LJ Biessels JG (2003 Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin-converting enzyme inhibitor. Diabetes Metab Res Rev 19 : 469 477.
15. Moffat AC, Osselton MD Widdop B (eds 2004 Clarke's Analysis of Drugs and Poisons.
16. Rachmani R, Lidar M, Levy Z Ravid M (2000 Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes. Eur J Intern Med 11 : 48 50.
17. Ritz E Haxsen V (2005 Diabetic nephropathy and anaemia. Eur J Clin Invest 35 (Suppl. 3 66 74.
18. Shargel L, Wu-Pong S You ABC (2005 Applied Biopharmaceutics & Pharmacokinetics.
19. Sigurdsson HH, Konradsdóttir F, Loftsson T Stefánsson E (2007 Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye. Acta Ophthalmol Scand 85 : 598 602.
20. Sweetman SC (ed 2002 Martindale, the Complete Drug Reference.
21. Trissel LA (ed 2003 Handbook on Injectable Drugs.
22. Tummel KE Shen DD (2001 Appendix II. Design and optimization of dosage regiments: pharmacokinetic data. In : Hardman JG, Limbird LE (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics.
23. Watkins RW, Baum T, Cedeno K, Smith EM, Yuen P-H, Ahn H-S Barnett A (1987 Topical ocular hypotensive effects of the novel angiotensin-converting enzyme inhibitor SCH 33861 in conscious rabbits. J Ocul Pharmacol 3 : 295 307.